Schrdinger, Inc. provides a physics-based software platform that enables the discovery of novel molecules for drug development and material applications. The company is headquartered in New York, New York.
| Revenue (TTM) | $254.91M |
| Gross Profit (TTM) | $141.04M |
| EBITDA | $-158.89M |
| Operating Margin | -83.30% |
| Return on Equity | -30.10% |
| Return on Assets | -15.00% |
| Revenue/Share (TTM) | $3.46 |
| Book Value | $4.21 |
| Price-to-Book | 3.17 |
| Price-to-Sales (TTM) | 3.90 |
| EV/Revenue | 2.753 |
| EV/EBITDA | -10.82 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -1.60% |
| Shares Outstanding | $65.56M |
| Float | $57.70M |
| % Insiders | 2.91% |
| % Institutions | 97.96% |
Volatility is currently expanding